Delivery Order SPE2DB20D2104-SPE2DB24FU03P
Award Date 5/6/24
Potential Completion Date 5/7/24
Potential Value $3.1K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $1,463.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,490,062 units of Ondansetron ODT 4 MG Tablet 30S, a medication used to treat nausea and vomiting. The award has an ultimate completion date of January 31, 2024 and is a Firm Fixed Price Delivery Order contract. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
- This federal contract award, worth $12,645.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a completion date of May 22, 2023 and is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $30,017.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a prescription medication used to prevent nausea and vomiting. The contract has an ultimate completion date of December 8, 2023 and is a Firm Fixed Price Delivery Order. The contract was awarded on December 7, 2022 without any set-aside designation, indicating open...
- This federal contract award, valued at $7,612.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4563004203 - Ondansetron ODT 4 mg Tablet 30s, a medication used to treat nausea and vomiting. The award is a Firm Fixed Price Delivery Order with a performance period ending on December 6, 2023. The contract was awarded through full and open competition, with no set-aside designation. Amerisourcebergen...
- This federal contract award was made to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA). The $16,790.43 firm-fixed-price delivery order is for Ondansetron HCL 8 mg tablets, a medication used to prevent nausea and vomiting. The award has an ultimate completion date of March 1, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Ondansetron ODT 8 mg tablets, a medication used to prevent nausea and vomiting, with a ceiling value of $5,358.06. The contract is a Firm Fixed Price Delivery Order, with a period of performance through May 3, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $3,677.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4563217759 units of Ondansetron ODT 4 mg tablets, which are used to treat nausea and vomiting. This is a firm-fixed-price delivery order contract with a completion date of January 4, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,856.01 firm fixed-price delivery order is for the supply of Ondansetron ODT 4 mg tablets, a medication primarily used to prevent nausea and vomiting. The award has an ultimate completion date of May 22, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award, valued at $10,806.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ondansetron ODT 4 MG Tablets in quantities of 30. This is a firm-fixed-price delivery order contract with an ultimate completion date of April 28, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $11,235.55 delivery order is for the supply of 4 mg Ondansetron ODT tablets, which are used to treat nausea and vomiting. The contract has an ultimate completion date of April 18, 2023 and is a firm fixed-price delivery order under the DLA's Indefinite Delivery Contract (IDC) with Cencora, Inc. valued at up to $999,999,999.00. This IDC serves as the...